Japanese Encephalitis Program
Japanese Encephalitis Virus Infection
Pre-clinicalActive
Key Facts
Indication
Japanese Encephalitis Virus Infection
Phase
Pre-clinical
Status
Active
About Integrated Research Associates
Integrated Research Associates, founded in 2007, is a private biotechnology company operating in both therapeutic development and research reagents. Its core mission is to address unmet medical needs posed by neurovirulent and globally spreading viruses like dengue, Zika, and Japanese encephalitis through drug and vaccine R&D. The company has a dual business model, combining early-stage, pre-clinical therapeutic programs with a commercial portfolio of validated viral antigens and antibodies for the research community. This provides a revenue stream while funding its internal development efforts.
View full company profile